INS and type 2 diabetes mellitus: Consistent with the previously reported ability of FGF21 administration to improve hyperglycaemia and enhance insulin sensitivity and glucose clearance [19, 20, 26, 44], we observed a protection from type 2 diabetes and beta cell loss independent of body fat.